tiprankstipranks
Trending News
More News >
Erasca (ERAS)
NASDAQ:ERAS
US Market

Compare Erasca (ERAS) vs. Competitors

Compare
313 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Erasca
$5.81
$1.65B
-12.89
111.27%
5 Buy
1 Hold
1 Sell
Moderate Buy
Arcturus Therapeutics
$6.77
$192.36M
-2.75
-64.27%
6 Buy
3 Hold
0 Sell
Moderate Buy
Arvinas Holding Company
$12.18
$782.25M
-15.17
-38.55%
6 Buy
3 Hold
1 Sell
Moderate Buy
Olema Pharmaceuticals
$25.57
$2.01B
-14.11
344.70%
11 Buy
0 Hold
0 Sell
Strong Buy
Bicara Therapeutics Inc.
$16.56
$907.19M
8.59%
8 Buy
2 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
ERAS
Erasca
5.81
3.66
170.23%
ARCT
Arcturus Therapeutics
6.77
-10.54
-60.89%
ARVN
Arvinas Holding Company
12.18
-5.83
-32.37%
OPT
OLMA
Olema Pharmaceuticals
25.57
20.73
428.31%
BCAX
Bicara Therapeutics Inc.
16.56
3.57
27.48%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts